ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL HEART, LUNG, AND BLOOD INSTITUTE

Macropinocytosis and Pulmonary Fibrosis

Active
Institution
Baylor College of Medicine, TX
Principal investigator
Konstantin Tsoyi
Funding
$596K
Duration
2025–2028
Open portfolio

Moonbase score

Still being scored

Abstract

PROJECT SUMMARY/ABSTRACT This R01 proposal describes a five-year research plan that will facilitate a research program dedicated to determining the roles of macropinocytosis and its molecular mechanisms in pulmonary fibrosis. Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, fibroproliferative interstitial lung disease whose etiology remains unknown. Little is known about the molecular mechanisms involved in the pathogenesis of IPF. This project will focus on elucidating the key roles of macropinocytosis in lung fibrogenesis, as well as their therapeutic applications. Macropinocytosis is an actin-dependent but clathrin-independent endocytic process that mediates the nonselective internalization of extracellular contents, such as proteins and free amino acids (AA). Macropinocytosis is one of the major routes of nutrient uptake from the extracellular environment for various cells and is known to be involved in cell survival, migration, and metabolism. However, the role of this process in lung fibrogenesis is currently unknown. Our preliminary findings suggest that the inhibition of macropinocytosis attenuates myofibroblast differentiation and lung fibrosis in mice. Here, we will determine whether macropinocytosis exerts profibrotic responses in lung fibroblasts and experimental pulmonary fibrosis. Further, we will also identify the molecular mechanisms by which macropinocytosis regulates profibrotic responses in activated lung fibroblasts. We will test our hypotheses by addressing the following Specific Aims: In Aim 1, we will assess whether macropinocytosis deficiency attenuates fibrosis in repetitive and aged models of pulmonary fibrosis, primary cell culture system and precision cut lung slices. In Aim 2, we will determine the effect of macropinocytosis-mediated amino acid uptake on the expression of profibrotic genes in activated lung fibroblasts. In Aim 3, we will assess the potential anti-fibrotic effect of macropinocytosis inhibitors in pulmonary fibrosis.

LOADING MOONBASE SCORE

NATIONAL HEART, LUNG, AND BLOOD INSTITUTER01Lung Injury, Repair, and Remodeling Study Section[LIRR]fibrosispulmonarylungmacropinocytosispulmonary fibrosisfibrogenesisipfprofibrotic

Questions for Baylor College of Medicine

Answered by the team behind this research.

Same institution, same topic, scored first.